Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000647990 | SCV000769800 | uncertain significance | Qualitative or quantitative defects of dysferlin | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid with valine at codon 1170 of the DYSF protein (p.Asp1170Val). The aspartic acid residue is moderately conserved and there is a large physicochemical difference between aspartic acid and valine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with DYSF-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001829802 | SCV002082285 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2021-06-25 | no assertion criteria provided | clinical testing |